Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Prog Urol ; 20(4): 239-50, 2010 Apr.
Article in French | MEDLINE | ID: mdl-20380985

ABSTRACT

AIM: Evaluate urinary continence after radical prostatectomy. MATERIALS AND METHOD: Recent series about urinary continence were studied. RESULTS: In seven articles analyzed, continence fluctuated between 63.6 and 91.9%. Evaluation benchmarks were depending on study. Unlike self-questionnaires, objective criteria (pad test) should be more reliable. Carcinologic prognostic factors were not implicated directly. The most frequently preoperative risk factors of incontinence were: age, BMI. Peroperative parameters, attesting of surgical difficulties could have a functional impact. Bladder neck preservation could affect the recovery velocity but not functional results. Length of catheterization and lack of urinary rehabilitation could be influent. The mean of continence evaluation after radical prostatectomy was different for each study. CONCLUSION: Comparability was difficult because operative technique, group's features and mean of functional evaluation were different from study to study. Several risk factors were found but without consensus. It would be necessary to separate carcinologic and functional risk factors.


Subject(s)
Laparoscopy , Prostatectomy/adverse effects , Prostatectomy/methods , Prostatic Neoplasms/surgery , Humans , Male , Urinary Incontinence
2.
Prog Urol ; 19(7): 501-6, 2009 Jul.
Article in French | MEDLINE | ID: mdl-19559382

ABSTRACT

AIM: To describe medium-term functional results of Transurethral Needle Ablation (TUNA) to treat symptomatic benign prostatic hyperplasia (BPH) refractory to medical treatment. MATERIALS AND METHOD: Patients who completed at least 2 years follow-up after TUNA were systematically offered a reevaluation including: Flowmetry, PSA, symptom score (IPSS), satisfaction index visual analogic scale (VAS) and a treatment impact evaluation with a Likert scale (ranging from much worse to much improved). RESULTS: From December 2002 to January 2007, 45 patients were treated with TUNA under local regional anaesthesia (prostatic block). Twenty-seven of them were followed-up longer than 24 months (median follow-up 44 months [26-52]). Changes in the selected outcomes were: increase in Qmax from 9.5 mL/s preoperatively to 9 mL/s at 6 month and 11.5 mL/s after 2 years; increase in IPSS from 19.3 before TUNA to 16.3 at 6 month and 16.5 after 2 years. About subjective evaluation, 58% of patient gave a satisfaction VAS>or=6, and the improvement index was greater or equal to +1 in 67% of case. CONCLUSION: In this initial monocentric experiment, despite a modest improvement of objective parameters and a 20% of retreatment rate, TUNA give contentment and improvement sensation for 60% of patients who were treated for non-efficiency of medical treatment for benign prostatic hyperplasia.


Subject(s)
Catheter Ablation , Prostatic Hyperplasia/surgery , Urination Disorders/surgery , Aged , Aged, 80 and over , Biomarkers, Tumor/blood , Dysuria/surgery , Follow-Up Studies , Humans , Male , Middle Aged , Patient Satisfaction , Prostate-Specific Antigen/blood , Prostatic Hyperplasia/complications , Prostatic Hyperplasia/immunology , Psychometrics , Retrospective Studies , Rheology , Surveys and Questionnaires , Time Factors , Treatment Outcome , Urinary Retention/surgery , Urination Disorders/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...